Peptide Reactivity Is a Threshold Event
Peptide Reactivity Is a Threshold Event, Understanding Histamine-Mediated Responses to Therapeutic Peptides By Chris Duffin Adverse responses to peptide therapy are frequently misclassified as allergic reactions or compound toxicity. In most cases, symptoms such as flushing, pruritus, injection site swelling, erythema, or transient anxiety are histamine mediated responses rather than IgE-driven allergies or contamination-related toxicity. […]